# Morphle Labs Inc.

> Morphle Labs is a deep-tech healthcare automation company building robotic and AI-driven imaging systems for cancer diagnostics. Founded in 2017 and now operating between Bengaluru and New York, it combines robotics, optical engineering, and neural-network AI to automate the historically manual steps of histology - from tissue sectioning to whole-slide scanning to remote reporting. Its product line spans the RoboTome robotic microtome, the MorphoLens family of whole-slide scanners, and the HemoLens hematology scanners, giving pathology labs an end-to-end digital workflow at a fraction of the cost of legacy systems.

- **Founded:** 2017
- **Headquarters:** New York, United States (R&D and manufacturing roots in Bengaluru, India)
- **Founders:** Rohit Hiwale (Co-Founder & CEO), Anchit Navelkar (Co-Founder)
- **Team size:** ~100 employees
- **Products:** RoboTome (RTM30), MorphoLens 240, MorphoLens 6, MorphoLens 1, HemoLens (1 / 16)
- **Notable:** Built what it calls the world's first high-throughput robotic microtome (RoboTome)., Filed 80+ patents across robotics, optics, and imaging., Raised $5M Series A from Inflexor Ventures in November 2025.

## Products & services

- **RoboTome (RTM30)** — The world's first high-throughput robotic microtome, automating tissue sectioning at 2x+ the speed of a manual histotechnologist with significant headcount savings.
- **MorphoLens 240** — High-throughput whole-slide scanner for high-volume labs, with a 240-slide capacity and integrated data management and LIS integration.
- **MorphoLens 6** — Mid-range whole-slide scanner optimized for up to 100 slides daily, praised by clinicians for resolution and image quality.
- **MorphoLens 1** — Compact, affordable single-slide whole-slide scanner for smaller labs and on-demand imaging.
- **HemoLens (1 / 16)** — Specialized scanners for hematology - peripheral blood smears, bone marrow aspirates, and CSF - using AI to detect and sort cells, including true 100x oil imaging.
- **RoboReq** — Medical-grade OCR that reads handwritten pathology requisitions using neural networks to automate lab intake.
- **Morphle Cloud / Viewer** — Software layer for whole-slide image storage, sharing, remote viewing, live microscopy, and tele-reporting with a compact image format that cuts storage roughly 4x.

## Achievements

- Built what it calls the world's first high-throughput robotic microtome (RoboTome).
- Filed 80+ patents across robotics, optics, and imaging.
- Raised $5M Series A from Inflexor Ventures in November 2025.
- Adopted by leading research institutions including Cedars-Sinai, Harvard, NIH, USC and the NHS.
- Reached commercial validation having raised comparatively little early capital (~₹1 crore to first product).

## Latest updates

- **2025-11** — Raised $5M Series A from Inflexor Ventures to scale manufacturing of RoboTome and MorphoLens, pursue international regulatory approvals, and expand globally.
- **2024** — Introduced RoboTome robotic microtome and RoboReq medical-grade OCR, extending automation upstream into tissue sectioning and lab intake.

## Links

- Website: https://morphlelabs.com
- LinkedIn: http://www.linkedin.com/company/morphle
- Twitter/X: https://x.com/morphledigipath
- YouTube: https://www.youtube.com/channel/UCcdDDly6C6XhKfKYto33P8w
- Instagram: https://www.instagram.com/morphlelabs/
- Facebook: https://www.facebook.com/morphlelabs

---

Profile page: https://yespress.io/morphle-labs-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-18